However, conflicting evidence suggests that DACH1 is highly expressed at all stages of CRC, and increased DACH1 expression was identified as an independent predictor of poor prognosis, highlighting its pro-tumorigenic role through the regulation of BMP signaling [11]. The gene discussed is DACH1; the disease is colorectal carcinoma.